AMZN
Amazon.com, Inc.
AMZN has the edge over KTB overall, supported by stronger valuation and stronger modeled upside.
KTB
Kontoor Brands, Inc.
KTB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
KTB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Strong | |
| Stable |
KTB's profitability and cash flow are currently healthy, and its balance sheet is stable, but its revenue is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over KTB in the historical PE scenario, which offers more potential upside but is not a forecast.
KTB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $40.20 | -48% |
| Fair | 16x | $57.23 | -26% |
| Expensive | 20x | $72.73 | -6.5% |
| Current | 22x | $77.76 | — |
Historical ranges are pointers, not guarantees.
KTB's PE is in its expensive range at 22x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
KTB Forward outlook
There aren't enough analyst estimates for KTB to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over KTB on earnings, with more consistent year-over-year improvement.
KTB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.59 | -7.2% |
| Q2 2026 | $4.79 | +7.2% |
| Q1 2026 | $4.94 | +21% |
| Q4 2025 | $4.05 | -7.1% |
| Q3 2025 | $3.87 | -13% |
| Q2 2025 | $4.47 | +5.7% |
| Q1 2025 | $4.07 | +3% |
| Q4 2024 | $4.36 | +7.4% |
KTB earned $3.59 per share over the past year, down 7.2% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over KTB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over KTB on profitability, with a higher operating margin.
KTB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $685.3M | -20% |
| Q2 2026 | $584.3M | -11% |
| Q1 2026 | $613.3M | -1.5% |
| Q4 2025 | $1B | +46% |
| Q3 2025 | $853.2M | +27% |
| Q2 2025 | $658.3M | +8.5% |
| Q1 2025 | $622.9M | -1.3% |
| Q4 2024 | $699.3M | +4.4% |
KTB's revenue has held roughly level: $685M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.8 points |
| Q2 2026 | 15% | +3.6 points |
| Q1 2026 | 15% | +2.9 points |
| Q4 2025 | 12% | -0.2 points |
| Q3 2025 | 7.5% | -7.2 points |
| Q2 2025 | 12% | -0.5 points |
| Q1 2025 | 12% | -1.6 points |
| Q4 2024 | 12% | +0.8 points |
KTB's operating margin was 11% last quarter, up 3.8 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
KTB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.3M | -15% |
| Q2 2026 | $45.4M | +103% |
| Q1 2026 | $40.3M | -46% |
| Q4 2025 | $281.8M | +276% |
| Q3 2025 | $55.8M | -57% |
| Q2 2025 | $22.4M | -76% |
| Q1 2025 | $74.9M | +44% |
| Q4 2024 | $75M | -63% |
KTB has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
KTB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -864K shares |
| 1 year | -2.6% | -1.4M shares |
| 3 years | -4.1% | -2.3M shares |
| 5 years | -7.8% | -4.7M shares |
| Available history | -4.5% | -2.6M shares |
KTB has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $20M |
| Q2 2026 | $50.4M |
| Q1 2026 | $25M |
| Q4 2025 | $25M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
KTB spent $120M buying back its own shares over the past year, after none the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over KTB on leverage, with a lower net debt burden relative to earnings.
KTB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.1x | Healthy |
KTB's net debt is about 2.5 years of its operating earnings (EBITDA), down from 3.6 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
KTB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.6 | Neutral |
| Stochastic | 56.5 | Neutral |
KTB's weekly RSI is 55 (neutral) and its Stochastic is 57 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over KTB on valuation relative to its sector.
KTB PE vs Consumer Cyclical Sector
| Metric | KTB | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 85 | 47 | 38 pts above |
KTB is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
KTB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.8 | 8.4% above |
| 20 week MA | $76.3 | 2% above |
| 50 week MA | $71.9 | 8.2% above |
| 100 week MA | $72.5 | 7.3% above |
| 200 week MA | $65.4 | 19% above |
KTB is in an uptrend: it's above all five of its weekly moving averages, and 19% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
KTB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.5 | $41.5 | -2.3% |
| 2021 | $41.5 | $50.9 | +23% |
| 2022 | $50.9 | $39.6 | -22% |
| 2023 | $39.6 | $62.4 | +58% |
| 2024 | $62.4 | $85.2 | +36% |
| 2025 | $85.2 | $62.9 | -26% |
| 2026 YTD | $62.9 | $77.8 | +24% |
KTB has the edge over AMZN on returns for 2026, with the stronger performance.